NCT06253260

Brief Summary

Analgesic Efficacy of Sequential Rapid Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine Versus Sequential Slow Injection of Both Drugs in Patients Undergoing Unilateral Inguinal Hernia Repair Surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at below P25 for not_applicable postoperative-pain

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 12, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

February 15, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2024

Completed
Last Updated

May 24, 2024

Status Verified

May 1, 2024

Enrollment Period

3 months

First QC Date

February 2, 2024

Last Update Submit

May 23, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Duration of postoperative analgesia

    time from reaching the sensory level of T6 until the need of first dose of rescue analgesia

    24 hours

Secondary Outcomes (4)

  • Onset of sensory block

    20 minutes

  • Onset of motor block using Bromage scale

    30 minutes

  • VIisual Visual analouge scale Visual analogue scale (VAS) score at 0.5-, 1-, 2-, 4-, 6-, 8-, 10-, 12-, 18-and 24-hour post operatively

    24 hrs

  • Total dose of postoperative pethidine

    24 hours

Study Arms (2)

(Group A): rapid sequential group

ACTIVE COMPARATOR
Drug: Analgesic Efficacy of Sequential Rapid Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine Injection in Patients Undergoing Unilateral Inguinal Hernia Repair

(Group B): normal sequential group

ACTIVE COMPARATOR
Drug: Analgesic Efficacy of Sequential Slow Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine in Patients Undergoing Unilateral Inguinal Hernia Repair Surgery

Interventions

Analgesic Efficacy of Sequential Rapid Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine Injection in Patients Undergoing Unilateral Inguinal Hernia Repair Surgery

(Group A): rapid sequential group

Analgesic Efficacy of Sequential Slow Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine in Patients Undergoing Unilateral Inguinal Hernia Repair Surgery

(Group B): normal sequential group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients undergoing inguinal hernia repair surgery.
  • Age between 18 years and 65 years.
  • Both sexes
  • ASA I \& ASA II

You may not qualify if:

  • Patients refusal
  • Pregnant women
  • Duration of surgery more than 2 hours.
  • Chronic use of opioids or tranquilizers.
  • Incooperative patients e.g mentally retarded.
  • Patients with any contraindications to spinal anesthesia
  • Allergy to the used drugs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr Alainy hospitals

Cairo, 11562, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor of Anesthesia, pain management & surgical ICU

Study Record Dates

First Submitted

February 2, 2024

First Posted

February 12, 2024

Study Start

February 15, 2024

Primary Completion

May 20, 2024

Study Completion

May 20, 2024

Last Updated

May 24, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations